Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997030070 - NOVEL COMPOUNDS

Publication Number WO/1997/030070
Publication Date 21.08.1997
International Application No. PCT/US1997/002318
International Filing Date 19.02.1997
Chapter 2 Demand Filed 17.09.1997
IPC
A61K 39/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
C07K 14/31 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
195from bacteria
305from Micrococcaceae (F)
31from Staphylococcus (G)
C07K 16/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
12against material from bacteria
CPC
A61K 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
A61P 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C07K 14/31
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
195from bacteria
305from Micrococcaceae (F)
31from Staphylococcus (G)
C07K 16/1275
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
12against material from bacteria
1267from Gram-positive bacteria
1275from Streptococcus (G)
C12N 9/78
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes; Proenzymes; Compositions thereof
14Hydrolases (3)
78acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Applicants
  • SMITHKLINE BEECHAM CORPORATION [US]/[US] (AllExceptUS)
  • BLACK, Michael, Terrance [GB]/[US] (UsOnly)
  • BURNHAM, Martin, Karl, Russel [US]/[US] (UsOnly)
  • HODGSON, John, Edward [GB]/[GB] (UsOnly)
  • KNOWLES, David, Justin, Charles [GB]/[GB] (UsOnly)
  • NICHOLAS, Richard, Oakley [GB]/[GB] (UsOnly)
  • PRATT, Julie, M. [GB]/[GB] (UsOnly)
  • REICHARD, Raymond, Winfield [US]/[US] (UsOnly)
  • ROSENBERG, Martin [US]/[US] (UsOnly)
  • WARD, Judith, M. [GB]/[GB] (UsOnly)
Inventors
  • BLACK, Michael, Terrance
  • BURNHAM, Martin, Karl, Russel
  • HODGSON, John, Edward
  • KNOWLES, David, Justin, Charles
  • NICHOLAS, Richard, Oakley
  • PRATT, Julie, M.
  • REICHARD, Raymond, Winfield
  • ROSENBERG, Martin
  • WARD, Judith, M.
Agents
  • GIMMI, Edward, R.
Priority Data
60/011,88820.02.1996US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NOVEL COMPOUNDS
(FR) NOUVEAUX COMPOSES
Abstract
(EN)
This invention relates to newly identified Staphylococcal polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells transformed with the polynucleotides. This invention also relates to inhibiting the biosynthesis or action of such polynucleotides or polypeptides and to the use of such inhibitors in therapy.
(FR)
La présente invention concerne des polynucléotides staphylococciques nouvellement identifiés, des polypeptides codés par de tels polynucléotides, l'utilisation de tels polynucléotides et polypeptides, ainsi que la production de tels polynucléotides et polypeptides et la production de cellules hôtes recombinantes transformées au moyen de ces polynucléotides. L'invention concerne également l'inhibition de la biosynthèse ou l'action de tels polynucléotides ou polypeptides ainsi que l'utilisation thérapeutique de tels inhibiteurs.
Latest bibliographic data on file with the International Bureau